4.8 Article

Biotransformation of organic micropollutants by anaerobic sludge enzymes

Journal

WATER RESEARCH
Volume 152, Issue -, Pages 202-214

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.watres.2018.12.064

Keywords

Anaerobic digestion; Degradation; Enzymatic transformation; Enzymatic pathways; Pharmaceuticals; Sewage treatment plant

Funding

  1. European Research Council through the EU-Project ATHENE [267897]
  2. Short Term Scientific Mission of the Water 2020 Cost Action [ES1202]
  3. Spanish Government through a FPU Grant [FPU13/01255]
  4. Spanish Government through COMETT project [CTQ2016-80847-R]
  5. Universidade de Santiago de Compostela [AGRUP2015/02, GRC ED431C 2017/29]
  6. FEDER (EU)
  7. European Research Council (ERC) [267897] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

Biotransformation of organic micropollutants (OMPs) in wastewater treatment plants ultimately depends on the enzymatic activities developed in each biological process. However, few research efforts have been made to clarify and identify the role of enzymes on the removal of OMPs, which is an essential knowledge to determine the biotransformation potential of treatment technologies. Therefore, the purpose of the present study was to investigate the enzymatic transformation of 35 OMPs under anaerobic conditions, which have been even less studied than aerobic systems. Initially, 13 OMPs were identified to be significantly biotransformed (>20%) by anaerobic sludge obtained from a full-scale anaerobic digester, predestining them as potential targets of anaerobic enzymes. Native enzymes were extracted from this anaerobic sludge to perform transformation assays with the OMPs. In addition, the effect of detergents to recover membrane enzymes, as well as the effects of cofactors and inhibitors to promote and suppress specific enzymatic activities were evaluated. In total, it was possible to recover enzymatic activities towards 10 out of these 13 target OMPs (acetyl-sulfamethoxazole and its transformation product sulfamethoxazole, acetaminophen, atenolol, clarithromycin, citalopram, climbazole, erythromycin, and terbutryn, venlafaxine) as well as towards 8 non-target OMPs (diclofenac, iopamidol, acyclovir, acesulfame, and 4 different hydroxylated metabolites of carbamazepine). Some enzymatic activities likely involved in the anaerobic biotransformation of these OMPs were identified. Thereby, this study is a starting point to unravel the still enigmatic biotransformation of OMPs in wastewater treatment systems. (C) 2019 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available